Sarvalakshmi Duriseti, MD | |
100 Medical Dr, Hannibal, MO 63401-6877 | |
(573) 221-5250 | |
Not Available |
Full Name | Sarvalakshmi Duriseti |
---|---|
Gender | Female |
Speciality | Allergy & Immunology - Allergy |
Location | 100 Medical Dr, Hannibal, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649418807 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 2008037611 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sarvalakshmi Duriseti, MD 100 Medical Dr, Po Box 311, Hannibal, MO 63401-6877 Ph: (573) 221-5250 | Sarvalakshmi Duriseti, MD 100 Medical Dr, Hannibal, MO 63401-6877 Ph: (573) 221-5250 |
News Archive
EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its new SilverStream(TM) solution for prescription use. The FDA also cleared DermaSept, an Over-the-Counter version of the SilverStream product.
EpiCept Corporation today announced that Health Canada has accepted for review the Company's New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of central nervous system (CNS) disorders including obesity, has presented the results of a preclinical study that further supports the Company's understanding of an aspect of the mechanism of action of Contrave, one of its two late-stage obesity drug candidates.
Robots in the cath lab are helping clear blocked arteries in patients — reducing chest pain, shortness of breath, and risks for heart attacks. The Orlando Health Heart Institute is the first in the state of Florida, to offer a robotic-assisted system for coronary angioplasty.
› Verified 7 days ago